First Amendment to Sublease Agreement by and between Surface Oncology, Inc. and EQRx International, Inc, dated July 9, 2020
Exhibit 10.2
FIRST AMENDMENT TO SUBLEASE AGREEMENT
THIS FIRST AMENDMENT TO SUBLEASE AGREEMENT (this “Amendment”) is
made as of July 9, 2020, by and between Surface Oncology, Inc., a Delaware corporation (“Sublessor”), and EQRx, INC., a Delaware Corporation (“Sublessee”).
RECITALS
NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:
Promptly after the occurrence of the Effective Date, Sublessor and Sublessee shall confirm the Effective Date in writing.
Work Letter. (a)The first paragraph of Section 1 of the Work Letter shall be amended by adding after (“Second Amendment”) the following:
“and the Third Amendment to Lease dated as of April 30, 2020 (“Third Amendment”)”
(b) The second paragraph of Section 1 of the Work Letter shall be amended by adding after each instance of “Second Amendment” the following:
“and Third Amendment”
3. | Miscellaneous. |
(Signatures on following page.)
IN WITNESS WHEREOF, Sublessor and Sublessee have duly executed this Amendment as an instrument under seal, as of the day and year first above written.
SUBLESSOR:
SURFACE ONCOLOGY, INC.
By: /s/ Jeff Goater 7/9/2020
Name: Jeff Goater
Title: CEO
SUBLESSEE:
EQRX, INC.
By: /s/ Melanie Nallicheri 7/9/2020
Name: Melanie Nallicheri
Title: President & COO